Articles tagged with Mutation
Researchers developed a genetic test for CMT2, a leading cause of the condition, which is characterized by muscle weakness and nerve damage. The new test offers hope for early diagnosis and potential treatment of CMT2, a complex disorder with no effective therapies yet.
Mutations in the progranulin gene cause frontotemporal dementia (FTD), a group of brain disorders affecting personality and speech. The discovery reveals the mechanism that causes the disease and points to potential therapeutic approaches.
Researchers discovered a genetic mutation in Florida beach mice that affects their coat color, revealing a possible explanation for the evolution of similar color patterns in extinct mammoths. The study also sheds light on the complex genetic process underlying coat pattern generation in mammals.
A recent genetic study discovered a link between beta-actin mutations and developmental brain disorders, including dystonia. The findings suggest that these mutations may play a wider role in a range of congenital diseases.
A 10-year study by U-M researchers found that women with BRCA1 or BRCA2 gene mutations who underwent breast-conserving surgery and hormonal treatment had lower rates of breast cancer recurrence. Tamoxifen reduced the risk of same-breast recurrence by 58 percent, while oophorectomy lowered the risk even further.
Researchers at ULg discovered a new kind of mutation that may contribute to the wide range of phenotypic variations observed in various species, including humans. The Patrocles database provides a comprehensive collection of these mutations, which can aid in discovering similar phenomena for other phenotypes and hereditary diseases.
A study of 886 women with BRCA1 or BRCA2 genetic mutations found that prophylactic surgery reduced ovarian cancer incidence by 89% and breast cancer incidence by 47%. The results differ for BRCA1 and BRCA2 carriers, highlighting the need for tailored risk-reduction strategies.
Scientists found that Cx26 mutations may have an evolutionary advantage due to their role in wound healing and defense against bacterial invasion. A drug temporarily knocking out Cx26 protein could improve healing in various epidermal wounds.
The Mayo Clinic team has discovered that an echocardiography-guided genetic test can be more effective in identifying hypertrophic cardiomyopathy (HCM) mutations, particularly when combined with unique anatomical features of the heart. This approach can help physicians provide more accurate counseling to families and unlock new researc...
Researchers pinpointed a single base pair mutation in DNA that causes non-shattering rice varieties, allowing for effective field harvests. This discovery will benefit the world by improving yields and sustainability of food crops, particularly rice, which is staple food for over half of the global population.
The COSMIC database has expanded to include data on 538 genes and 124,367 tumours, highlighting the need for further research to uncover additional breast cancer susceptibility genes. Scientists believe that many somatic mutations are caused by a combination of faulty gene and environmental factors.
A study found that commercial genetic testing does not detect all cancer-predisposing mutations in BRCA1, BRCA2, CHEK2, TP53, and PTEN among women with breast cancer from high-risk families. The researchers identified previously undetected mutations in 17% of patients, highlighting the need for more accurate genetic testing methods.
Researchers found no association between mammography and increased risk of breast cancer in women with BRCA mutations. The study suggests that screening may be safe for this high-risk group, but prospective studies are needed to confirm the results.
Researchers have identified a genetic mutation in the calnexin gene that can lead to degenerative blindness, providing new insights into retinal degeneration. The study's findings may one day enable doctors to deliver tailored treatments to patients with specific calnexin mutations.
A genetic mutation, CCR5delta32, makes individuals more susceptible to West Nile virus infections. Research suggests that this lack of a protein can prevent protective immune cells from reaching the brain, increasing the risk of severe disease.
Researchers propose a three-step process for cancer development, where epigenetic changes occur first, followed by genetic mutations. This new understanding may lead to earlier detection and treatment of cancer, similar to cholesterol-lowering drugs preventing heart disease.
Researchers identified 235 different mutations in 310 patients, with 70% of Romano Ward probands successfully genotyped using standard methods. The new approach aims to facilitate genetic testing for LQTS in a broader group of individuals, including those receiving QT-interval prolonging drugs and family members.
Researchers developed a system to trace lineage on a large scale by analyzing genetic mutations in microsatellites, creating accurate cell lineage trees for living cells. The method uses a computer algorithm to analyze genetic information and assess degrees of relatedness.
A study found that larger DNA bases can lead to increased efficiency in DNA replication, allowing for more genetic mutations. This discovery sheds light on the mechanisms underlying genetic evolution.
Researchers found that individuals carrying CDKN2A mutations have a significantly higher risk of developing melanoma by age 50 (14%), 70 (24%), and 80 (28%). Genetic testing is unlikely to identify many mutation carriers due to the modest impact of these mutations on population incidence.
Researchers at EMBL have discovered two types of EJC complexes that determine how NMD deals with defective RNA molecules. The presence or absence of a protein called UPF2 affects the composition of the EJC, influencing how NMD recognizes and breaks down faulty RNAs.
A study found that the BRCA2 gene mutation significantly increases cancer risk in men, with higher rates of prostate, pancreatic, pharyngeal and bone cancers. The mutation is associated with an increased risk of developing these cancers, particularly among younger men.
Researchers have made significant progress in understanding the genetic mutations that cause familial migraines. By studying how these mutations affect the sodium pump, a crucial cellular mechanism, Dr. Rhoda Blostein and her team identified key changes that disrupt its operation, leading to migraine development.
A new study links aging to genetic mutations in mitochondria, accelerating cell death and critical organ failure. Researchers found that accumulated mitochondrial DNA damage triggers cell death, leading to symptoms like hair loss, weight loss and vision impairment.
Researchers at Ludwig Maximillians University report that AML1-ETO cooperates with FLT3 to induce rapid and aggressive acute leukemia in mice. This study supports a pathogenetic model of acute leukemia, which requires activating mutations in signal transduction pathways and transcription factors for leukemogenesis.
A new gene scanning technique called meltMADGE enables the discovery of rare genetic variations associated with various diseases. Researchers analyzed nearly 10,000 middle-aged individuals and found associations with high cholesterol levels and potential protective effects.
Researchers have identified a regulatory element within the 52-kilobase deletion region responsible for Van Buchem disease. This discovery provides strong causal evidence linking the deletion to the disease and opens up new avenues for understanding bone formation and potentially developing therapeutic agents.
A study of 11,800 adults found that genetic screening for haemochromatosis was well-received by participants, with low anxiety levels and no discrimination from insurance companies. The authors argue that the benefits of screening outweigh the risks, making it a cost-effective option for preventing iron accumulation.
Researchers discover risk-increasing mutation in non-coding region of RET gene associated with Hirschsprung disease, challenging traditional focus on protein-coding sequences. The study highlights the importance of non-coding regions in disease development.
Researchers found no causative mutations in MEF2A gene among patients with premature coronary heart disease. This challenges the role of MEF2A in causing CAD and suggests another genetic variant may be responsible.
A new Standard Reference Material, SRM 2394, has been developed by NIST researchers to aid in the detection of low-frequency mutations in heteroplasmic DNA. The material provides a set of mixtures at 10 certified concentrations of two DNA fragments differing at one position.
A recent study found that the LRRK2 gene mutation is associated with Parkinson's disease in several families, indicating a genetic component of the disease. The mutation was identified in 22 out of 42 family members who carried the G2019S mutation, and all shared a common ancestral pattern.
Researchers find that mice with a double dose of IGF2 develop more precursor cells in the colon, doubling cancer risk when combined with a colon-cancer-causing genetic mutation. This epigenetic problem may contribute to colon cancer development.
A new Standard Reference Material from NIST will help clinical genetics labs accurately count fragile-X repeat sequences. The SRM 2399 consists of nine DNA samples with triplet repeats ranging from 20 to 118, ensuring quality control and check on test procedures.
A team of 138 undergraduate students, led by HHMI professor Banerjee, identified essential genes in eye formation using a novel genetic method. The students created flies with specific mutations, allowing them to study the impact of these mutations on the eye.
Researchers at Johns Hopkins Medicine have discovered a new syndrome characterized by wide-set eyes, cleft palate, or split uvula, and aggressive swelling of the aorta. Early diagnosis and treatment can prevent aortic rupture and save lives, with surgery often successful if performed promptly.
A single gene mutation in the LRRK2 gene has been identified as a cause of around one in 25 cases of Parkinson's disease worldwide. The mutation is associated with both inherited and sporadic forms of the disease, suggesting new diagnostic and treatment options on the horizon.
A new genetic mutation on the LRRK2 gene is responsible for 5% of inherited Parkinson's disease cases, with patients having longer disease duration but less severe symptoms. The discovery has a broad implication for genetic screening for the disease, highlighting the need to include studies of the LRRK2 gene in future testing.
A study found that a mutation in the LRRK2 gene appears in at least one of every 60 people with Parkinson's disease. The mutation may account for 1½ to 2 percent of cases, particularly those without a family history, and could lead to earlier detection of the disease.
A recent study found that the LRRK2 mutation is the most common genetic cause of Parkinson's disease, affecting approximately 5% of patients. This mutation is linked to slower disease progression, while symptoms are less severe compared to other mutations in the gene.
Biologists at UCSD identified a gene regulating plant branching, which they believe was crucial in transforming teosinte into maize. The researchers found numerous variants of the gene in teosinte but only one variant in modern maize, suggesting targeted human selection may have played a key role.
Researchers followed 87 women diagnosed with BRCA mutations who underwent BCT and found no increase in cancer recurrence risk. However, more than half suffered a cancer-related event within ten years, including 37.6% with new cancers in the untreated breast.
Genetic variation in ABCA1 transporter contributes to reduced HDL cholesterol levels in the general population. The study found that specific mutations affect HDL levels, with lower levels associated with a higher risk of cardiovascular disease.
A study published in Clinical Genetics found that genetic testing for a rare cancer syndrome saved $16,900 per year for 54 family members. The test also identified two asymptomatic family members who underwent prophylactic surgery to significantly decrease their risk of cancer.
A single genetic mutation in mitochondrial genes has been found to be associated with multiple risk factors for heart disease and stroke, including hypertension, high cholesterol, and low magnesium levels. The researchers also discovered a link between the mutation and other conditions such as hearing loss and weakened heart muscle.
Researchers identify genetic mutations in the N-terminal domain of the MC4R protein that contribute to obesity, providing a promising new strategy for treating the condition. The study suggests that drugs targeting sustained low-level MC4R activity may be effective in regulating appetite.
A study found genetic mutations in 16.3% of individuals with no lung cancer, associated with polycyclic aromatic hydrocarbons from smoky coal emissions. Women in Xuan Wei have an abnormally high lung cancer death rate despite low tobacco smoking rates.
A mouse study has identified a potential genetic link between NPAS3 and NPAS1 genes and psychosis. The mutated mice displayed deficits consistent with schizophrenia, including impaired social interaction and startle response. Further research is needed to confirm the connection.
Researchers discovered over 2,200 new human-specific Alu DNA repeats not found in chimpanzees, suggesting an explosive expansion of genetic code. This finding contradicts the idea of natural selection and highlights a chemical process driving human evolution.
A new study has identified 11 genetic mutations in SIDS cases, with a significant association found in African American babies. The study suggests that these mutations may contribute to the increased risk of SIDS in this ethnic group.
A study of 60 Korean women with breast cancer found a high rate of genetic mutations in BRCA1 and BRCA2 genes. The average age of diagnosis was 40-50 years old, which is younger than in the US population. The study suggests different genetic and environmental factors may be at play for Korean patients diagnosed at a young age.
A novel mutation in the SCN1A gene has been discovered in a family with generalized epilepsy with febrile seizures plus (GEFS+), a condition characterized by unusual brain activity. This finding may lead to improved diagnoses, treatments, and genetic counseling for affected individuals.
Researchers have detected a Senataxin gene mutation that may contribute to the degeneration of motor neuron cells in a rare form of ALS. This discovery opens up avenues of investigation for understanding and treating other forms of motor neuron diseases.
Mayo Clinic researchers found gene mutations that disrupt stress signaling in the heart, making it vulnerable to damage. The study, published in Nature Genetics, may lead to new treatments for heart failure.
A genetic mutation in the CCR5 gene does not offer protection against HIV infection, according to new research by Scripps scientist Donald Mosier. The study tested the hypothesis that the mutation, which appeared in Europe during the Middle Ages, protected against both HIV and plague.
Researchers have discovered a new hereditary cancer mutation associated with an increased risk of colon, endometrial and ovarian cancers. The mutation was found in descendants of a German immigrant who arrived in the US in 1727.
A team of researchers at Stanford University used a computer simulation to trace the origins of genetic mutations in human populations. By modeling population growth, migration, and mutation rates, they were able to estimate the location and time of origin for these genetic changes.
A genetic mutation that disables a protein used by HIV-1 to infect cells is prevalent in 10% of Europeans due to historical smallpox exposure. This mutation, which protects against death from smallpox, has been transferred to AIDS, slowing its progression.
Researchers found one presenilin gene mutation associated with variable age of onset AD (from 35 to 85 years old) and two new presenilin gene mutations linked to early onset AD at age 49 to 54 years old. The study confirms the clinical manifestation of PS1 and PS2 gene mutations in Alzheimer's disease is similar to other dementias.
A study led by Dr. Lawrence C. Layman aims to identify genetic mutations contributing to delayed puberty, which may lead to better infertility treatment and birth control options. By analyzing the function of hundreds of genes, researchers hope to uncover potential treatments for this condition, which affects about 1% of the population.